Attached files
file | filename |
---|---|
10-K - CASI Pharmaceuticals, Inc. | v178789_10k.htm |
EX-32.1 - CASI Pharmaceuticals, Inc. | v178789_ex32-1.htm |
EX-31.1 - CASI Pharmaceuticals, Inc. | v178789_ex31-1.htm |
EX-31.2 - CASI Pharmaceuticals, Inc. | v178789_ex31-2.htm |
EX-32.2 - CASI Pharmaceuticals, Inc. | v178789_ex32-2.htm |
EXHIBIT 23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the following Registration
Statements:
(1)
|
Registration
Statement Number 333-26057 on Form
S-8
|
(2)
|
Registration
Statement Number 333-67063 on Form
S-8
|
(3)
|
Registration
Statement Number 333-41218 on Form
S-8
|
(4)
|
Registration
Statement Number 333-68048 on Form
S-8
|
(5)
|
Registration
Statement Number 333-101617 on Form
S-8
|
(6)
|
Registration
Statement Number 333-80193 on Form
S-3
|
(7)
|
Registration
Statement Number 333-84907 on Form
S-3
|
(8)
|
Registration
Statement Number 333-76824 on Form
S-3
|
(9)
|
Registration
Statement Number 333-104380 on Form
S-3
|
(10)
|
Registration
Statement Number 333-110604 on Form
S-3
|
(11)
|
Registration
Statement Number 333-122309 on Form
S-3
|
(12)
|
Registration
Statement Number 333-133190 on Form
S-3
|
(13)
|
Registration
Statement Number 333-132715 on Form
S-3
|
(14)
|
Registration
Statement Number 333-151542 on Form
S-3
|
(15)
|
Registration
Statement Number 333-161100 on Form
S-3
|
of our
reports dated March 29, 2010, with respect to the consolidated financial
statements of EntreMed, Inc. and the effectiveness of internal control over
financial reporting of EntreMed, Inc., included in this Annual Report (Form
10-K) for the year ended December 31, 2009.
/s/ Ernst & Young LLP
McLean,
VA
March 29,
2010